N-protein vaccine is effective against COVID-19: Phase 3, randomized, double-blind, placebo-controlled clinical trial.
Rabdano SO, Ruzanova EA, Vertyachikh AE, Teplykh VA, Emelyanova AB, Rudakov GO, Arakelov SA, Pletyukhina IV, Saveliev NS, Lukovenko AA, Fakhretdinova LN, Safi AS, Zhirenkina EN, Polyakova IN, Belozerova NS, Klykov VV, Savelieva AP, Ekimov AA, Pokachalov KV, Merkulov VA, Yudin SM, Kruchko DS, Berzin IA, Skvortsova VI; Clinical Trial Group.
Rabdano SO, et al. Among authors: yudin sm.
J Infect. 2024 Nov;89(5):106288. doi: 10.1016/j.jinf.2024.106288. Epub 2024 Sep 26.
J Infect. 2024.
PMID: 39341405
Free article.
Clinical Trial.